XCAP.P Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Exelerate Capital Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.03 |
| 52 Week High | CA$0.05 |
| 52 Week Low | CA$0.025 |
| Beta | 0.71 |
| 11 Month Change | -14.29% |
| 3 Month Change | n/a |
| 1 Year Change | -14.29% |
| 33 Year Change | -70.00% |
| 5 Year Change | -70.00% |
| Change since IPO | -80.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| XCAP.P | CA Capital Markets | CA Market | |
|---|---|---|---|
| 7D | -40.0% | -1.8% | 0.2% |
| 1Y | -14.3% | 65.6% | 21.0% |
Return vs Industry: XCAP.P underperformed the Canadian Capital Markets industry which returned 65.6% over the past year.
Return vs Market: XCAP.P underperformed the Canadian Market which returned 21% over the past year.
Price Volatility
| XCAP.P volatility | |
|---|---|
| XCAP.P Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 5.6% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 17.5% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: XCAP.P's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine XCAP.P's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Mark Kohler | n/a |
Exelerate Capital Corp. does not have significant operations. It intends to identify and evaluate businesses or assets with a view to complete a qualifying transaction. The company was formerly known as Exelerate Health Inc. and changed its name to Exelerate Capital Corp. in February 2019.
Exelerate Capital Corp. Fundamentals Summary
| XCAP.P fundamental statistics | |
|---|---|
| Market cap | CA$315.61k |
| Earnings (TTM) | -CA$47.78k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-6.6x
P/E RatioIs XCAP.P overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| XCAP.P income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$47.78k |
| Earnings | -CA$47.78k |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0045 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did XCAP.P perform over the long term?
See historical performance and comparison